# BETAMETHASONE DIPROPIONATE
> **ANDA215186** · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2022-02-18
## Drug
- **FDA Application Number:** ANDA215186
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BETAMETHASONE DIPROPIONATE
- **Generic name:** BETAMETHASONE DIPROPIONATE USP, 0.05%
- **Active ingredients:** BETAMETHASONE DIPROPIONATE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** TP ANDA HOLDINGS
- **Manufacturer:** TruPharma LLC
- **First approval:** 2022-02-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215186)
---
*AI Analytics · CC0 1.0*